CLAPS, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 5.249
AS - Asia 4.896
EU - Europa 3.207
SA - Sud America 770
AF - Africa 150
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.322
Nazione #
US - Stati Uniti d'America 5.013
SG - Singapore 1.768
CN - Cina 1.113
IT - Italia 890
BR - Brasile 546
HK - Hong Kong 512
SE - Svezia 427
VN - Vietnam 397
KR - Corea 317
FR - Francia 272
DE - Germania 223
GB - Regno Unito 203
IN - India 193
RU - Federazione Russa 182
NL - Olanda 165
PL - Polonia 154
CA - Canada 137
FI - Finlandia 112
TR - Turchia 110
JP - Giappone 89
IE - Irlanda 87
BG - Bulgaria 83
ES - Italia 81
AR - Argentina 79
CH - Svizzera 62
MX - Messico 62
ID - Indonesia 54
AT - Austria 52
MA - Marocco 48
BD - Bangladesh 46
CO - Colombia 43
BE - Belgio 41
PK - Pakistan 40
AU - Australia 38
IR - Iran 38
UA - Ucraina 35
EC - Ecuador 28
IQ - Iraq 27
PH - Filippine 27
ZA - Sudafrica 26
CL - Cile 25
RO - Romania 23
TW - Taiwan 23
SA - Arabia Saudita 21
TN - Tunisia 18
CZ - Repubblica Ceca 17
EG - Egitto 17
MY - Malesia 16
VE - Venezuela 15
PT - Portogallo 14
KE - Kenya 13
LT - Lituania 13
TH - Thailandia 13
JO - Giordania 12
IL - Israele 11
PY - Paraguay 11
UZ - Uzbekistan 11
NP - Nepal 10
AL - Albania 9
GR - Grecia 9
BO - Bolivia 8
HU - Ungheria 8
PE - Perù 8
KZ - Kazakistan 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
CR - Costa Rica 6
DK - Danimarca 6
HR - Croazia 6
AZ - Azerbaigian 5
GE - Georgia 5
GH - Ghana 5
JM - Giamaica 5
NO - Norvegia 5
OM - Oman 5
QA - Qatar 5
SN - Senegal 5
CI - Costa d'Avorio 4
ET - Etiopia 4
KG - Kirghizistan 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
EU - Europa 3
GT - Guatemala 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
RS - Serbia 3
BS - Bahamas 2
DZ - Algeria 2
EE - Estonia 2
GA - Gabon 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
Totale 14.297
Città #
Singapore 1.064
Ashburn 584
San Jose 510
Hong Kong 490
Chandler 332
Seoul 297
Hefei 282
Beijing 238
Chicago 230
Trieste 211
Fairfield 186
Los Angeles 167
Boardman 144
Ho Chi Minh City 139
Ann Arbor 117
Princeton 114
Seattle 113
Wilmington 113
Lauterbourg 107
Columbus 101
Zgierz 96
Santa Clara 95
Houston 87
Hanoi 83
Woodbridge 82
Sofia 80
Dublin 79
Milan 78
The Dalles 76
Moscow 74
São Paulo 74
Cambridge 68
Helsinki 66
Dallas 65
Frankfurt am Main 60
Council Bluffs 57
Toronto 55
New York 52
Bern 49
London 49
Jacksonville 48
Buffalo 45
Rome 42
Salt Lake City 42
Munich 41
Warsaw 41
Orem 40
Elk Grove Village 37
Guangzhou 37
Shanghai 37
Tokyo 36
Redwood City 35
Casablanca 33
Lappeenranta 32
Vienna 31
Atlanta 28
Brussels 28
Tampa 28
Chennai 25
Nuremberg 25
Redmond 24
Boston 23
Montreal 23
Istanbul 22
Phoenix 22
San Diego 22
Ankara 21
Palermo 21
Washington 21
Madrid 20
Rio de Janeiro 20
Brooklyn 19
Manchester 19
Paris 19
Bogotá 18
Denver 18
Haiphong 18
Tehran 18
North Bergen 17
Pune 17
Redondo Beach 17
Norwalk 16
Sterling 16
Amsterdam 15
Buenos Aires 15
Düsseldorf 15
Johannesburg 15
Poplar 15
Da Nang 14
Dhaka 14
Jakarta 14
Stockholm 14
Bengaluru 13
Curitiba 13
Lahore 13
Lancaster 13
Mexico City 13
Dong Ket 12
Hamilton 12
Izmir 12
Totale 8.358
Nome #
Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer 517
MtF sex reassignment surgery: Trombetta technique 462
Gender affirming surgery: Vaginoplasty and clitoroplasty with modified peno-scrotal flap technique 409
Preoperative impact of albumin to fibrinogen ratio (AFR) on oncological outcomes in patients with muscle invasive bladder cancer treated with radical cystectomy 274
Focal testicular lesions. Multiparametric us features and association with histopathology 268
Warm ischemia time length during on-clamp partial nephrectomy: dose it really matter? 260
Utility of serum markers in the assessment of perioperative and postoperative morbidity and mortality after radical cystectomy 258
Testis sparing surgery: Results of a large multicentric retrospective study 254
Testis Sparing Surgery of Small Testicular Masses: Retrospective Analysis of a Multicenter Cohort 244
Analysis of clinical utility of abdominopelvic computer tomography in the follow up of Stage I Seminoma. A single center evaluation 230
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients 204
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy 202
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy 198
The role of preoperative controlling nutrtional status (CONUT) score in the assessment of pathological features and survival outcomes in clear-cell renal cell carcinoma (ccRCC): A population-based study 186
Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer 182
P-04-10 Italian Residents in Urology Sexual Health: A Multicentric Study 176
Learning Curve for Endoscopic Combined Intra-Renal Surgery Using Vacuum-Assisted Device 175
Impact of preoperative Controlling nutritional status (CONUT) score on perioperative morbidity and survival outcomes in patients with bladder cancer treated with radical cystectomy 171
Analysis of clinical utility of abdominopelvic computer tomography in the surveillance of stage I seminoma. A single center evaluation 170
Reliable Prediction of Post-Operative Complications’ Rate Using the G8 Screening Tool: A Prospective Study on Elderly Patients Undergoing Surgery for Kidney Cancer 168
An Observational Cohort Study Investigating the Incidence Rate of Infectious Complications After Routine Office Nephrostomy Tube Replacement Without Using Antimicrobial Prophylaxis 166
MP80-05 TREND, CHARACTERISTICS AND IMPACT ON CANCER-SPECIFIC MORTALITY OF INCIDENTAL RENAL MASSES: RESULTS FROM A LARGE SERIES OF AUTOPSIES 166
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets 164
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry 164
PD60-10 IMPACT OF PREOPERATIVE CONTROLLING NUTRITIONAL STATUS (CONUT) SCORE ON PERIOPERATIVE MORBIDITY AND SURVIVAL OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A MULTICENTER ANALYSIS 158
Impact of the COVID-19 pandemic on urology residency training in Italy 156
Infective complications after nephrostomy tube replacement without use of antimicrobical prophylaxis: A prospective study 152
Improving pre-operative planning of robot assisted nephron sparing surgery using three-dimensional anatomical model 151
Analysis of Bacterial Stent Colonization: The Role of Urine and Device Microbiological Cultures 151
The role of preoperative cart score as predictor of renal functional decline after partial nephrectomy 148
Rebiopsy rate after transperineal or transrectal prostate biopsy 148
External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study 143
The role of preoperative controlling nutritional status (CONUT) score in the assessment of survival outcomes in patients with muscle invasive bladder cancer (MIBC) treated with radical cystectomy: A pilot study 142
The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer 140
Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration 140
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study 140
Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy 139
Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives 139
Reliability of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: A precision study 139
Optimization of the different therapeutic strategies in muscle invasive bladder cancer using biomarkers 139
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 138
Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy 138
Procalcitonin as prognostic factor in patients with Fournier's gangrene 137
Impact of antiplatlet or anticoagulation therapy in patients newly diagnosed bladder cancer: Preliminary results of a independent analysis of the Identify Study Italian cohort 137
Double-Layered Hand-Sewn versus Stapled Intestinal Anastomosis in Patients Who Underwent Ileal Urinary Diversion in Radical Cystectomy: A Comparative and Cost Effective Study 136
Preliminary results from an independent analysis of the italian cohort of the identify study: Baseline features of italian patients investigated for suspicious urinary tract malignancy at 5 italian tertiary referral centers 136
Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy 136
Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility 135
Management of stuttering priapism 135
Validation of the Italian version of wisconsin stone quality of life (WISQOL): a prospective Italian multicenter study 133
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis 132
Risk factors of bladder cancer in patients undergoing transurethral cystoscopy: A multicentric italian experience from the IDENTIFY study cohort 131
Time for a change in the management of small testicular masses: Results of a large multicentric retrospective study on testis sparing surgery 129
Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores 127
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 126
MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE 125
Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study 125
Intraoperative laparoscopic ICG-guidance extended pelvic lymph node dissection in patients with intermediate and high-risk prostate cancer who underwent radical prostatectomy: A matched case-control study 120
Plication surgery does not produce additional loss of length in Peyronie’s disease patients 118
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study 117
Fluorescence Confocal Microscopy in Urological Malignancies: Current Applications and Future Perspectives 115
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 115
Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer 114
COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers 113
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 111
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature 109
External validation of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: a multicentric prospective study 109
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum 108
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival 108
Arterioureteral fistula: An unusual cause of haematuria 10 years after the implantation of a synthetic iliac-femoral stent 105
Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function? 104
Focus on the Use of Resveratrol in Bladder Cancer 104
MP46-17 INFECTIVE COMPLICATIONS AFTER NEPHROSTOMY TUBE REPLACEMENT WITHOUT USE OF ANTIMICROBICAL PROPHYLAXIS: A PROSPECTIVE STUDY 104
The IDENTIFY Study: The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study 101
The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma 100
Smart learning for urology residents during the COVID-19 pandemic and beyond: insights from a nationwide survey in Italy 100
The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series 98
Novel Expanding Renal Cell Carcinoma Biomarkers 97
Targeted Prostate Biopsy: How, When, and Why? A Systematic Review 96
Editorial Comment [to "Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes"] 96
Exploring the Residents’ Perspective on Smart learning Modalities and Contents for Virtual Urology Education: Lesson Learned During the COVID-19 Pandemic 95
Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective study 95
Reply by Authors 89
Slowdown of urology residents’ learning curve during the COVID-19 emergency 88
Promising Biomarkers in Renal Cell Carcinoma 87
MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRY 85
Laroscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of Indocyanine Green: Results from a prospective study 83
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 82
Frequency of testicular torsion presenting with abdominal pain in adults: a retrospective analysis of diagnostic and management implications 81
Laparoscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of indocyanine green: Results from a prospective study 81
Prostate cancer patients with lymphatic node involvement detected by immunohistochemistry. Is the effort worthwhile? 79
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 79
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy 78
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy 75
Molecular markers of systemic therapy response in urothelial carcinoma 74
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis? 74
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) 68
Novel Expanding Renal Cell Carcinoma Biomarkers 67
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer 65
Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy 64
Totale 14.300
Categoria #
all - tutte 47.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021204 0 0 0 0 0 0 0 0 0 80 41 83
2021/2022845 34 67 75 110 25 26 37 55 121 99 31 165
2022/20231.393 127 205 76 180 62 204 51 127 178 55 77 51
2023/20241.483 103 75 79 81 121 138 289 224 42 56 151 124
2024/20253.356 102 257 364 317 270 269 212 158 447 370 264 326
2025/20266.417 966 412 600 685 525 607 877 289 654 802 0 0
Totale 14.756